Expert Outlook: Carter's Through The Eyes Of 5 Analysts
Portfolio Pulse from Benzinga Insights
Carter's (NYSE:CRI) has been the subject of varied analyst ratings over the past three months, with a recent shift towards a more bearish outlook. Despite this, the average 12-month price target for CRI has increased to $73.4, up from $67.80. Analysts from Citigroup, UBS, Evercore ISI Group, and Wedbush have adjusted their ratings and price targets, reflecting changing market dynamics and company performance. Carter's faces revenue challenges with a -5.95% decline over 3 months but maintains strong profitability indicators such as a net margin of 12.18% and ROE of 12.82%.
April 18, 2024 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Carter's has seen a mix of analyst ratings, with a recent bearish trend but an increase in the average price target to $73.4. The company's revenue has declined by -5.95% over the past three months, yet it maintains strong profitability metrics.
The mixed analyst ratings with a recent increase in bearish outlooks could create uncertainty among investors, potentially leading to short-term volatility in CRI's stock price. However, the increase in the average price target suggests underlying confidence in the company's value proposition. The reported revenue decline poses a concern, but the strong profitability metrics, including net margin and ROE, indicate a solid financial foundation that could mitigate negative impacts and support the stock's resilience in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100